4
Changes in Ownership
Design Therapeutics, Inc. Filed Acc 0001209191-23-048222
Options or other derivatives
- President, CEO and Chairperson acquired 2,100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shah Pratik President, CEO and Chairperson | 2023-09-01 | Grant or award · Stock Option (right to buy) | +1,050,000 | 1,050,000 | D: show line 1 in the form | ||
| Shah Pratik President, CEO and Chairperson | 2023-09-01 | Grant or award · Stock Option (right to buy) | +525,000 | 525,000 | D: show line 2 in the form | ||
| Shah Pratik President, CEO and Chairperson | 2023-09-01 | Grant or award · Stock Option (right to buy) | +525,000 | 525,000 | D: show line 3 in the form |
Loading xslF345X05/doc4.xml…